AP NEWS

U.S. Age-Related Macular Degeneration: 2018 Market and Competitive Landscape - ResearchAndMarkets.com

December 12, 2018

DUBLIN--(BUSINESS WIRE)--Dec 12, 2018--The “U.S. Age-Related Macular Degeneration Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive insights into Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.

The research is classified into following sections - Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Age-Related Macular Degeneration prevalence trends by countries; Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Key Topics Covered

1. Age-Related Macular Degeneration: Disease Overview

1.1. Age-Related Macular Degeneration Symptoms

1.2. Age-Related Macular Degeneration Etiology

1.3. Age-Related Macular Degeneration Diagnosis

1.4. Age-Related Macular Degeneration Treatment Options

2. Age-Related Macular Degeneration Pipeline Insights

2.1. Age-Related Macular Degeneration Phase 3 Clinical Trials

2.2. Age-Related Macular Degeneration Phase 2 Clinical Trials

2.3. Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Age-Related Macular Degeneration Epidemiology Analysis

4. US Age-Related Macular Degeneration Market Insights

4.1. Marketed Products for Age-Related Macular Degeneration in US

4.2. US Age-Related Macular Degeneration Market Size & Forecast

4.3. US Age-Related Macular Degeneration Product Sales Forecast

List of Tables

Table 1: Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2018

Table 2: Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2018

Table 3: Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2018

Table 4: Age-Related Macular Degeneration Prevalence , US, 2017 - 2023

Table 5: Marketed Products for Age-Related Macular Degeneration in US, 2017

Table 6: US Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023

Table 7: US Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023

List of Figures

Figure 1: Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2018

Figure 2: Age-Related Macular Degeneration Prevalence, US, 2017 - 2023

Figure 3: US Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023

Figure 4: US Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023

Figure 5: US Age-Related Macular Degeneration Market Share by Products (%), 2017

Figure 6: US Age-Related Macular Degeneration Market - Future Market Share (%), 2023

For more information about this report visit https://www.researchandmarkets.com/research/rmscbg/u_s_agerelated?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181212005283/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical Disorders Drugs

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/12/2018 04:42 AM/DISC: 12/12/2018 04:42 AM

http://www.businesswire.com/news/home/20181212005283/en

AP RADIO
Update hourly